Suppr超能文献

韩国药物性耳毒性的初步分析:来自全国样本数据集的趋势

Preliminary Analysis of Drug-Induced Ototoxicity in South Korea: Trends From a National Sample Dataset.

作者信息

Aldahan Zahra, Kim Jiwon, Yoon Chul Young, Seo Young Joon, Park Kyoung Ho

机构信息

Department of Otolaryngology-Head & Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Research Institute of Hearing Enhancement, Yonsei University Wonju College of Medicine, Wonju, Korea.

出版信息

J Audiol Otol. 2025 Apr;29(2):110-116. doi: 10.7874/jao.2024.00493. Epub 2025 Apr 18.

Abstract

BACKGROUND AND OBJECTIVES

Certain medications are associated with ototoxicity. This study assesses drug-induced ototoxicity in South Korea by analyzing the Korean national health data.

SUBJECTS AND METHODS

Hospital records of National Health Insurance members from 2009 to 2016 were reviewed. Data were compared between patients with and without hearing loss (HL). Individuals with HL were identified as having a primary diagnosis code for sensorineural HL or another type of HL in at least one outpatient or inpatient record according to the International Classification of Diseases-10.

RESULTS

The members in the HL group increased slightly from 0.8% to 1.0% relative to the total sample, compared with 99.2% to 99.0% among the controls. The proportion of males in the HL group ranged from 45.6% to 47.6%, compared with 48.4% to 48.8% among the controls. The proportion of those aged ≥65 years in the HL group increased from 34.1% to 41.4%, compared with 10.6% to 13.3% among the controls. Hypertension prevalence (24.7%-25.7%) in the HL group was higher than that in the control group (12%-12.6%). Diabetes prevalence in the HL group was 10.6%-12.3%, compared with 4.4%-5.9% among the controls. The use of proton pump inhibitor components increased, particularly esomeprazole magnesium trihydrate and rabeprazole sodium, whereas the usage of pantoprazole sodium sesquihydrate and revaprazan was high initially but declined subsequently. The usage of painkillers such as acetaminophen, loxoprofen sodium, and ibuprofen remained high, and antibiotics such as cephalosporins indicated the highest usage. However, the use of penicillin antibiotics such as amoxicillin decreased significantly. Anticancer agents showed relatively low usage compared with other drug categories, whereas antihistamines showed extremely high usage across all years, with a continual increase.

CONCLUSIONS

These correlations and the underlying mechanisms necessitate further investigation, as several medicines have been linked to an increased risk of HL.

摘要

背景与目的

某些药物与耳毒性有关。本研究通过分析韩国国家健康数据评估韩国药物性耳毒性情况。

对象与方法

回顾了2009年至2016年国民健康保险参保人员的医院记录。对有听力损失(HL)和无听力损失的患者数据进行了比较。根据国际疾病分类第10版,HL患者被确定为在至少一份门诊或住院记录中有感音神经性HL或其他类型HL的主要诊断代码。

结果

HL组成员相对于总样本略有增加,从0.8%增至1.0%,而对照组从99.2%降至99.0%。HL组男性比例在45.6%至47.6%之间,而对照组在48.4%至48.8%之间。HL组中≥65岁者的比例从34.1%增至41.4%,而对照组在10.6%至13.3%之间。HL组高血压患病率(24.7% - 25.7%)高于对照组(12% - 12.6%)。HL组糖尿病患病率为10.6% - 12.3%,而对照组为4.4% - 5.9%。质子泵抑制剂成分的使用增加,尤其是三水合埃索美拉唑镁和雷贝拉唑钠,而泮托拉唑钠倍半水合物和瑞伐拉唑最初使用量高但随后下降。对乙酰氨基酚、洛索洛芬钠和布洛芬等止痛药的使用量仍然很高头抱菌素类等抗生素的使用量最高。然而,阿莫西林等青霉素类抗生素的使用量显著下降。与其他药物类别相比,抗癌药的使用量相对较低,而抗组胺药在所有年份的使用量都极高且持续增加。

结论

由于几种药物与HL风险增加有关,这些相关性及潜在机制需要进一步研究。

相似文献

本文引用的文献

1
Safety of fluoroquinolones.氟喹诺酮类药物的安全性。
Rev Esp Quimioter. 2024 Apr;37(2):127-133. doi: 10.37201/req/143.2023. Epub 2023 Dec 22.
2
Drug-induced hearing loss: Listening to the latest advances.药物性听力损失:聆听最新进展
Therapie. 2024 Mar-Apr;79(2):283-295. doi: 10.1016/j.therap.2023.10.011. Epub 2023 Oct 31.
4
Hear and Now: Ongoing Clinical Trials to Prevent Drug-Induced Hearing Loss.闻声而动:正在进行的预防药物性耳聋临床试验。
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:211-230. doi: 10.1146/annurev-pharmtox-033123-114106. Epub 2023 Aug 10.
5
Proton pump inhibitor use: systematic review of global trends and practices.质子泵抑制剂的使用:全球趋势和实践的系统评价。
Eur J Clin Pharmacol. 2023 Sep;79(9):1159-1172. doi: 10.1007/s00228-023-03534-z. Epub 2023 Jul 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验